• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保乳手术治疗导管原位癌患者切缘近切缘的发生率和后果:是否需要进一步治疗?

Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2013 Dec;20(13):4103-12. doi: 10.1245/s10434-013-3194-0. Epub 2013 Aug 23.

DOI:10.1245/s10434-013-3194-0
PMID:23975313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4337951/
Abstract

BACKGROUND

The impact of close margins in patients with ductal carcinoma-in situ (DCIS) treated with mastectomy is unclear; however, this finding may lead to a recommendation for postmastectomy radiotherapy (PMRT). We sought to determine the incidence and consequences of close margins in patients with DCIS treated with mastectomy.

METHODS

The records of 810 patients with DCIS treated with mastectomy from 1996 through 2009 were reviewed. Clinical and pathologic factors were analyzed with respect to final margin status. Median follow-up was 6.3 years.

RESULTS

Overall, 94 patients (11.7 %) had close margins (positive, n = 5; negative but ≤1 mm, n = 54; 1.1-2.9 mm, n = 35). Independent risk factors for close margins included multicentricity, pathologic lesion size ≥1.5 cm, and necrosis, but not age, use of skin-sparing mastectomy, or immediate reconstruction (p > 0.05). Seven patients received PMRT, and none had a locoregional recurrence (LRR). Among the remaining 803 patients, the 10-year LRR rate was 1 % (5.0 % for margins ≤1 mm, 3.6 % for margins 1.1-2.9 mm, and 0.7 % for margins ≥3 mm [p < 0.001]). The 10-year rate of contralateral breast cancer was 6.4 %. On multivariate analysis, close margins was the only independent predictor of LRR (p = 0.005).

CONCLUSIONS

Close margins occur in a minority of patients undergoing mastectomy for DCIS and is the only independent risk factor for LRR. As the LRR rate in patients with close margins is low and less than the rate of contralateral breast cancer, PMRT is not warranted except for patients with multiple close/positive margins that cannot be surgically excised.

摘要

背景

在接受乳房切除术治疗的导管原位癌(DCIS)患者中,切缘接近的影响尚不清楚;然而,这一发现可能导致推荐行乳房切除术后放疗(PMRT)。我们旨在确定接受乳房切除术治疗的 DCIS 患者中切缘接近的发生率和后果。

方法

回顾了 1996 年至 2009 年期间接受乳房切除术治疗的 810 例 DCIS 患者的记录。分析了临床和病理因素与最终切缘状态的关系。中位随访时间为 6.3 年。

结果

总体而言,94 例(11.7%)患者切缘接近(阳性,n=5;阴性但≤1mm,n=54;1.1-2.9mm,n=35)。切缘接近的独立危险因素包括多中心性、病变大小≥1.5cm 和坏死,但与年龄、是否采用保留皮肤的乳房切除术或即刻重建无关(p>0.05)。7 例患者接受了 PMRT,无局部区域复发(LRR)。在其余 803 例患者中,10 年 LRR 率为 1%(切缘≤1mm 为 5.0%,切缘 1.1-2.9mm 为 3.6%,切缘≥3mm 为 0.7%[p<0.001])。10 年对侧乳腺癌发生率为 6.4%。多变量分析显示,切缘接近是 LRR 的唯一独立预测因素(p=0.005)。

结论

在接受乳房切除术治疗的 DCIS 患者中,切缘接近的情况较为少见,是 LRR 的唯一独立危险因素。由于切缘接近患者的 LRR 率较低,且低于对侧乳腺癌的发生率,除非存在多处无法手术切除的切缘接近/阳性,否则不推荐行 PMRT。

相似文献

1
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?保乳手术治疗导管原位癌患者切缘近切缘的发生率和后果:是否需要进一步治疗?
Ann Surg Oncol. 2013 Dec;20(13):4103-12. doi: 10.1245/s10434-013-3194-0. Epub 2013 Aug 23.
2
Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.年龄对伴或不伴微浸润的导管原位癌行乳房切除术患者的局部区域和远处复发的影响。
Ann Surg Oncol. 2019 Dec;26(13):4264-4271. doi: 10.1245/s10434-019-07693-1. Epub 2019 Aug 22.
3
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy.保乳手术中乳晕后切缘或冰冻切片假阴性患者的局部区域复发风险。
Ann Surg Oncol. 2012 Dec;19(13):4117-23. doi: 10.1245/s10434-012-2514-0. Epub 2012 Jul 21.
4
Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.保乳手术后导管原位癌切缘状态对局部复发的影响。
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):948-52. doi: 10.1016/j.ijrobp.2012.07.2377. Epub 2012 Sep 11.
5
Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.导管原位癌(DCIS)的乳房切除术切缘:18年随访
Am J Surg. 2023 Nov;226(5):646-651. doi: 10.1016/j.amjsurg.2023.07.012. Epub 2023 Jul 14.
6
Comparison of local recurrence after mastectomy for pure ductal carcinoma with close or positive margins: A meta-analysis.保乳术后切缘阴性或近切缘的单纯导管癌局部复发的比较:一项荟萃分析。
J Cancer Res Ther. 2020 Oct-Dec;16(6):1197-1202. doi: 10.4103/jcrt.JCRT_160_19.
7
Is the Number or Proximity of Margins Less than 2 mm Associated with an Increased Mastectomy Rate in Patients Attempting Breast Conservation Therapy for Ductal Carcinoma In Situ?对于尝试保乳疗法治疗导管原位癌的患者,切缘长度或距离小于 2 毫米是否与乳房切除术率增加相关?
Ann Surg Oncol. 2024 Oct;31(11):7609-7618. doi: 10.1245/s10434-024-15794-9. Epub 2024 Jul 31.
8
Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.导管原位癌患者行单纯乳房切除术与保乳乳房切除术后局部复发情况的比较。
Ann Surg Oncol. 2017 Apr;24(4):1071-1076. doi: 10.1245/s10434-016-5673-6. Epub 2016 Nov 11.
9
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.1657例乳腺单纯导管原位癌患者的微钙化:与临床、组织病理学、生物学特征及局部复发的相关性
Ann Surg Oncol. 2016 Feb;23(2):482-9. doi: 10.1245/s10434-015-4876-6. Epub 2015 Sep 28.
10
Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.新辅助化疗后保乳手术患者的手术切缘与局部复发的关系。
BMC Cancer. 2020 May 20;20(1):451. doi: 10.1186/s12885-020-06955-6.

引用本文的文献

1
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study.保乳手术、乳腺切除术和单纯乳房切除术治疗导管原位癌患者的局部区域复发风险比较:一项单中心研究。
Breast Cancer. 2024 Nov;31(6):1010-1017. doi: 10.1007/s12282-024-01613-2. Epub 2024 Jul 17.
2
Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer".乳房切除术后残留纤维腺体组织与局部复发或新发原发性乳腺癌的风险增加相关。
BMC Cancer. 2023 Mar 28;23(1):281. doi: 10.1186/s12885-023-10764-y.
3
Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.导管原位癌的治疗:当代个性化治疗的考量
Curr Breast Cancer Rep. 2020 Jun;12(2):98-106. doi: 10.1007/s12609-020-00360-5. Epub 2020 Feb 24.
4
Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.年龄对伴或不伴微浸润的导管原位癌行乳房切除术患者的局部区域和远处复发的影响。
Ann Surg Oncol. 2019 Dec;26(13):4264-4271. doi: 10.1245/s10434-019-07693-1. Epub 2019 Aug 22.
5
[Update of the German S3 breast cancer guideline : What is new for pathologists?].[德国S3乳腺癌指南更新:病理学家的新内容有哪些?]
Pathologe. 2019 Mar;40(2):185-198. doi: 10.1007/s00292-019-0578-3.
6
Current Therapeutic Approaches to DCIS.导管原位癌的当前治疗方法。
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):279-291. doi: 10.1007/s10911-018-9415-1. Epub 2018 Sep 29.
7
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.预防性乳房切除术预防乳腺癌:文献综述
Avicenna J Med. 2018 Jul-Sep;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.
8
Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.导管原位癌患者行单纯乳房切除术与保乳乳房切除术后局部复发情况的比较。
Ann Surg Oncol. 2017 Apr;24(4):1071-1076. doi: 10.1245/s10434-016-5673-6. Epub 2016 Nov 11.
9
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.1657例乳腺单纯导管原位癌患者的微钙化:与临床、组织病理学、生物学特征及局部复发的相关性
Ann Surg Oncol. 2016 Feb;23(2):482-9. doi: 10.1245/s10434-015-4876-6. Epub 2015 Sep 28.
10
Ductal Carcinoma In Situ: Treatment Update and Current Trends.导管原位癌:治疗进展与当前趋势
Curr Oncol Rep. 2015 Nov;17(11):48. doi: 10.1007/s11912-015-0473-x.

本文引用的文献

1
Outcomes in patients treated with mastectomy for ductal carcinoma in situ.接受乳房切除术治疗导管原位癌患者的结局。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e129-34. doi: 10.1016/j.ijrobp.2012.10.020. Epub 2012 Nov 27.
2
Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.保乳手术后导管原位癌切缘状态对局部复发的影响。
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):948-52. doi: 10.1016/j.ijrobp.2012.07.2377. Epub 2012 Sep 11.
3
Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?保乳术后放疗在导管原位癌中是否有作用?
Int J Surg Oncol. 2012;2012:423520. doi: 10.1155/2012/423520. Epub 2012 Jun 13.
4
Post mastectomy radiotherapy in breast cancer: a survey of current United Kingdom practice.乳腺癌乳房切除术后放疗:英国当前实践调查
J BUON. 2012 Apr-Jun;17(2):245-8.
5
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.DCIS 中的生物学标志物与乳腺癌复发风险:系统评价。
J Cancer. 2011 May 1;2:232-61. doi: 10.7150/jca.2.232.
6
Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.分析保乳手术后 DCIS 复发的风险:USC/Van Nuys 预后指数的新用途。
Ann Surg Oncol. 2011 Feb;18(2):459-62. doi: 10.1245/s10434-010-1335-2. Epub 2010 Sep 22.
7
Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?对于导管原位癌且切缘接近阳性或阳性的患者,是否需要进行放射治疗?
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):25-30. doi: 10.1016/j.ijrobp.2010.01.044. Epub 2010 Jun 18.
8
Recurrence after mastectomy for ductal carcinoma in situ.导管原位癌乳房切除术后复发
Am Surg. 2009 Jul;75(7):592-5; discussion 595-7.
9
Ductal carcinoma in situ: state of the science and roadmap to advance the field.导管原位癌:科学现状与推动该领域发展的路线图。
J Clin Oncol. 2009 Jan 10;27(2):279-88. doi: 10.1200/JCO.2008.18.3103. Epub 2008 Dec 8.
10
Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy.导管原位癌乳房切除术后切缘阴性或阳性:复发模式及放疗的潜在指征
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1016-20. doi: 10.1016/j.ijrobp.2008.06.1954.